Expertise provided by James Collins, Owner
You have been through detox twice and residential once. You lasted three weeks on Suboxone before the side effects, and the feeling of being trapped on another drug, sent you back to fentanyl. Now someone has mentioned ibogaine for fentanyl addiction at Iboga Wellness Institute, and you want to know whether it is a real medical option or one more thing that sounds better than it is.
Maybe you are not the one using. Maybe you are the parent, spouse, or adult child reading this at the kitchen table after another phone call you dreaded. You have watched someone you love come home from program after program, and each time the hope fades a little more.
That caution makes sense. You have heard big promises before, and every failed attempt cost money, trust, time, and some of your belief that anything will work.
So here is where honesty starts. Ibogaine is not a cure. It is a powerful, investigational medicine that may interrupt withdrawal and quiet cravings for some people, though response varies considerably from person to person. It also carries real heart risks. It is not FDA-approved, and it is a Schedule I controlled substance in the United States. That is why IWI (Iboga Wellness Institute) provides ibogaine treatment only at its medical clinic in Cozumel, Mexico, and only after careful screening. The Columbus, Ohio office handles admissions, screening, and aftercare coordination. No ibogaine is given there.
This page covers what makes fentanyl so hard to quit, what the research does and does not show, how screening and treatment work, and what the first thirty days at home look like. By the end, you should be able to decide whether this deserves a conversation.
Why Fentanyl Is Different and Why Conventional Treatment Often Fails
Fentanyl is harder to quit than older opioids for three reasons. It is far stronger. It lingers in the body in ways that complicate withdrawal and medication starts. And the street supply shifts from batch to batch. None of that means you or your loved one failed. It means you have been fighting a harder drug with tools built for an easier one.
The National Institute on Drug Abuse describes fentanyl as up to 50 times stronger than heroin and 100 times stronger than morphine. Fentanyl also dissolves easily in fat. With heavy, daily use, it can build up in body tissue and release slowly. That helps explain why withdrawal can feel unpredictable, hitting hard, easing, then returning. It is also why some people have a rough start on buprenorphine. If the medicine goes in while fentanyl is still active, it can trigger sudden, intense withdrawal. Many people who quit Suboxone early were not weak. They had a bad induction and never wanted to feel that again.
Then comes the question of what was really in the supply. For the IWI clinical team, the single biggest gap between pharmaceutical fentanyl and today’s street fentanyl is not chemistry alone. It is uncertainty. A pharmaceutical product is a known drug in a known formulation, and the person often has a dependable dosing history. Street fentanyl cut with carfentanil or nitazenes can swing in contents and strength from one batch to the next. That makes it harder to forecast how someone should be prepared and how long their recovery may take.
The Iboga Wellness Institute team is equally careful about what that uncertainty does not prove. IWI does not claim that people exposed to carfentanil or nitazenes have particular outcomes with ibogaine, because strong comparative clinical evidence on that question does not exist, and observations from individual patients have to be read within that limit. Carfentanil and some nitazenes are far more potent than fentanyl, which raises serious overdose and breathing concerns. Nitazenes are also a family of drugs with differing properties, so one exposure cannot be assumed to act like another. Potency by itself does not reveal how long withdrawal will last or how a person will respond to ibogaine.
Suspected exposure is also not the same as confirmed exposure. Being told a batch held carfentanil or nitazenes does not establish what was actually taken. A negative fentanyl test strip does not rule out every dangerous substance, and some strips may miss carfentanil. So the Iboga Wellness Institute medical team does not plan around the word “fentanyl.” It plans around the person in front of it: pattern of use, previous overdoses, other substances or medications, current withdrawal symptoms, and medical findings. Two people who believe they used the same drug can arrive with very different needs.
One point deserves to be said clearly before going further. Medications like methadone and buprenorphine save lives, and for many people they work. If you or your loved one is stable on one right now, that is a real win. Nothing on this page is a reason to stop a medication without talking to a prescriber.
What Is Used to Treat Fentanyl Withdrawal?
Fentanyl withdrawal is most often treated with FDA-approved medications, mainly buprenorphine and methadone, along with supportive medical care. Naltrexone is used after withdrawal to help prevent a return to use. Ibogaine is a different approach that is not FDA-approved and is only available outside the United States.
Here is how the main options compare when the drug involved is fentanyl:
| Approach | How it works | Status in the US | What to know with fentanyl |
|---|---|---|---|
| Methadone | Full opioid agonist taken daily | FDA-approved, dispensed through licensed programs | May ease withdrawal for many people; usually long-term daily dosing |
| Buprenorphine (Suboxone) | Partial opioid agonist | FDA-approved, prescribed by clinicians | Starting it too soon after fentanyl can trigger sudden, severe withdrawal in some people |
| Naltrexone (extended-release) | Blocks opioid receptors | FDA-approved | You typically must be fully off opioids first, which is hard with fentanyl |
| Ibogaine | Acts on several brain systems at once | Not FDA-approved; Schedule I | Investigational; requires cardiac screening and medical monitoring abroad |
If you have tried the first three, you know the patterns. Methadone often means frequent clinic visits that shape a whole life around a dosing window. Buprenorphine works for many people, but for others the side effects, a painful induction, or the sense of being tied to another drug becomes too much. Naltrexone asks you to get all the way through withdrawal first, and with fentanyl that wall can feel impossible to climb.
That gap is where people start searching for ibogaine for fentanyl addiction. They want something that addresses the physical dependence and the mental grip together, rather than managing one and hoping the other fades.
IWI’s levels of care include detox and withdrawal management, residential care, MAT, and ibogaine treatment. That range matters, because ibogaine is not right for everyone. When screening shows ibogaine carries too much risk for a person, the honest answer is to say so and talk about safer paths.
Is Ibogaine Effective for Fentanyl Addiction?
Early research suggests ibogaine can reduce opioid withdrawal and cravings for some people, though outcomes vary widely and no large randomized controlled trials have tested it. Very little published research looks at fentanyl specifically.
Two studies come up often. Noller and colleagues, publishing in the American Journal of Drug and Alcohol Abuse in 2018, followed a small group of people in New Zealand for twelve months after ibogaine treatment for opioid dependence. They reported reduced withdrawal symptoms and, for many participants, reduced or stopped opioid use during the observation period. Mash and colleagues, publishing in Frontiers in Pharmacology the same year, reported fewer withdrawal signs and lower craving scores in people who received ibogaine during opioid detox in a clinical setting. At IWI, the clinical team has documented some cases in which people with years of daily fentanyl use reported withdrawal that had eased dramatically within forty-eight hours, though many others experience slower or partial relief, and individual response varies in ways that cannot be predicted, though not everyone responds that quickly or that completely.
All of these are observational studies. They had no control groups, the samples were small, and most participants were using heroin or prescription opioids, not today’s fentanyl supply. They show a signal worth taking seriously, but they do not establish that ibogaine works in a predictable way across different people and circumstances.
Why might ibogaine affect withdrawal and cravings at once in some people? A recent review of ibogaine’s therapeutic potential and cardiac safety explains that ibogaine and its long-lasting byproduct, noribogaine, act on several systems together, including opioid receptors, serotonin signaling, dopamine pathways, and NMDA receptors. People often call this a “reset.” A more careful description is that ibogaine seems to ease withdrawal while lowering the pull to use in some cases, and noribogaine stays in the body long enough that the effect may outlast the treatment itself in those who respond. That same broad activity explains the cardiac risk, which is why the screening section below matters so much.
IWI will not promise you a particular outcome. With today’s mixtures, the clinical picture is less predictable, and no one can responsibly predict an ibogaine response based on the suspected drug alone. Early relief matters when it occurs, but it is not the same thing as sustained recovery.
Does Ibogaine Get Rid of Withdrawals?
Ibogaine can reduce fentanyl withdrawal symptoms for many people, but it does not erase them for everyone. Some people still have lingering symptoms, such as poor sleep, low energy, or restlessness, in the days after treatment, while others experience more complete relief, individual response varies considerably.
Fentanyl’s tendency to linger in body tissue is one reason results vary. Use pattern, exposure history, and physical health all shape how withdrawal unfolds. That is why the Iboga Wellness Institute medical team decides when someone is stable and appropriate for treatment rather than following a fixed calendar. An uncertain exposure history can justify extra evaluation and observation. It does not automatically mean a longer stay, and the team will not assume that a set number of days, or a particular ibogaine dose, produces a predictable outcome.
After the flood dose, IWI looks past a simple “my withdrawal is better” or “my cravings are gone.” Sleep, appetite, physical stability, emotional functioning, and the ability to take part in ongoing care all count. One person can feel dramatically better on day two and still need close support on day ten.
There is also a serious safety point you need to hear plainly. After any break from opioids, including after ibogaine, tolerance drops. If a person returns to fentanyl at their old amount, the risk of a fatal overdose is much higher. This is one of the biggest reasons the Iboga Wellness Institute aftercare plan exists, and why keeping naloxone at home makes sense for anyone with a history of opioid use.
What Cardiac Screening Is Required Before Ibogaine Treatment?
Before anyone receives ibogaine at IWI, they go through comprehensive medical screening, including a 12-lead ECG to measure the QTc interval, along with a review of heart history, medications, and substance use. Screening is the gatekeeper, and not everyone passes.
The reason is the heart’s electrical rhythm. Ibogaine can lengthen the QT interval, the time the heart takes to reset between beats. When that interval stretches too far, it can lead to dangerous arrhythmias. The University of Virginia toxicology overview of ibogaine describes cardiac toxicity as the central safety concern with this medicine. Long-term fentanyl use, other substances in the street supply, and certain medications can all add to that risk.
Screening at IWI includes:
- A 12-lead ECG to measure the QTc interval and look for rhythm problems
- Comprehensive medical screening covering health history and current medications
- Testing that is interpreted honestly, separating what results confirm from what remains unknown
- Medical review of cardiovascular history before any treatment decision
- A frank look at use pattern, previous overdoses, and other substances
- Mental health screening, because some conditions make ibogaine inappropriate
Some people will not qualify, and acceptance is never guaranteed by applying or paying. IWI does not provide ibogaine to people with serious cardiovascular conditions, to people with psychosis, or to people with certain bipolar disorder presentations. It does not provide ibogaine during an acute psychiatric emergency or an active suicidal crisis. If you or your loved one is in crisis right now, please seek emergency help first.
Treatment can wait. Safety cannot.
For people who are accepted, protection continues through treatment at Iboga Wellness Institute with 24/7 nursing care and medical monitoring during the flood dose and the hours that follow. You can read more about that medical structure in our medical detox program overview.
How Is Ibogaine Administered for Fentanyl Addiction?
Ibogaine is given as a flood dose at IWI’s medical clinic in Cozumel, Mexico, only after screening and stabilization, and always under medical supervision with round-the-clock nursing. No ibogaine treatment happens in the United States, where the drug is Schedule I and not FDA-approved.
If an online search made it look like treatment happens closer to home in Ohio, it does not. Columbus is where Iboga Wellness Institute admissions, screening, and aftercare coordination happen. The treatment itself happens in Cozumel. You deserve to know that before you take a single step.
Here is the sequence from first contact to going home:
- Admissions and medical review. You speak with the admissions team, share your history, and complete screening, including the 12-lead ECG, before any travel is booked.
- Travel to the Cozumel clinic. Once the medical team clears you, you travel to the clinic, ideally with a support person.
- Preparation and stabilization. The team confirms your condition on arrival. Timing depends on your stability, not a calendar.
- The flood dose. You receive ibogaine at a dose set for you, not from a fixed protocol, with 24/7 nursing care and medical monitoring.
- Post-dose monitoring and rest. Monitoring continues while cardiac risk remains, and you rest and regain your balance.
- Discharge planning and aftercare. You leave with a written discharge plan and a clear path into integration and local support.
What does the experience feel like? Most people describe it as long, demanding, and deeply inward. Many report dreamlike images, memories surfacing, or a sense of reviewing their life from the outside. Nausea, unsteady walking, and sensitivity to light and sound are common, which is one reason Iboga Wellness Institute nurses stay with you around the clock. It is not a party drug experience, and most people do not call it pleasant. Many do call it meaningful.
For a deeper look at the whole process, see our complete guide to ibogaine treatment.
What Happens in the First Thirty Days After Treatment?
The treatment itself is only the beginning. The first thirty days largely decide whether the ibogaine experience turns into lasting recovery or fades like earlier attempts. IWI builds those weeks around one-on-one integration, group integration, local clinical care, a workable daily routine, and scheduled follow-ups at one week and one month.
For someone coming off fentanyl, discharge means stepping straight back into home, relationships, and daily pressure. IWI puts heavy weight on this window so that each person goes home with a clear aftercare plan and specific people to lean on while they start applying what they learned.
Individual integration and group integration do different jobs, and the team values having both. In one-on-one sessions, you can speak openly about what surfaced during treatment and what has happened since you got home, whether that is hard emotions, family strain, cravings, poor sleep, or uncertainty about the next step. The goal is to move past retelling the ibogaine experience and into concrete questions. What has to change this week? Which situations are straining your recovery? Who will you call when it gets hard?
Group integration supplies connection and accountability. Home can feel isolating when nobody around you has been through the same thing. A group is a place to be understood, to hear how others work through setbacks, and to speak up before a rough day turns into withdrawal from people. The Iboga Wellness Institute team asks clients to keep showing up on good days too, because bonds formed early make reaching out easier later.
Remote integration is valuable, but it is one piece of a larger plan. IWI wants each person connected to support where they live, including an appropriate local addiction clinician or therapist and a recovery community they are genuinely willing to join. If symptoms or cravings start getting hard to manage, that needs clinical attention, not only an integration conversation.
Motivation also has to become a routine. That means guarding time for appointments and groups, eating regular meals, resting, and thinking carefully about the people and places waiting at home. You may leave feeling energized, but you still need a plan for an argument with family, a brutal workday, or a message from someone you used with. The Iboga Wellness Institute team wants you to name those moments in advance and rehearse your response, so you are not relying on willpower when it counts.
Families come back in here. With the client’s permission, a trusted family member or support person can join the plan. That person should understand it, know how to back it up, and know whom to contact if something seems wrong. The one-week and one-month follow-ups at Iboga Wellness Institute check how the person is functioning, whether they are staying connected to care, and whether the plan needs adjusting. Clients are encouraged to reach out between those check-ins whenever they need help.
If you or your family ask exactly what is “required,” the answer is in the client’s written Iboga Wellness Institute discharge plan: the agreed frequency of individual sessions, group participation, and clinical follow-up, built for that person rather than handed out as a universal schedule. The core message is simple. No one should have to get through those first thirty days alone.
What Does Ibogaine Treatment Cost and How Do You Get There from Ohio?
IWI does not accept insurance. Because ibogaine is not FDA-approved, plan to pay for treatment out of pocket, along with travel to Cozumel. The admissions team can walk you through the full cost and what it includes before you commit.
This matters most if your family has already spent heavily on rehab. No insurance plan, including Ohio Medicaid, will pay for ibogaine treatment at the Iboga Wellness Institute clinic. Knowing that up front beats learning it after building your hopes around a coverage promise that was never real. Your own insurance may still help with the local side of aftercare, such as visits with an addiction clinician or therapist near home, depending on your plan.
When you compare any ibogaine program, ask what the price actually covers. Does it include the 12-lead ECG and medical screening? 24/7 nursing? Monitoring during and after the flood dose? Integration sessions and follow-ups once you are home? A lower price that leaves out monitoring or aftercare is not a bargain, because it shifts the risk onto you.
Getting there from Columbus, Cleveland, Cincinnati, or anywhere else in Ohio means international travel. Plan for a valid passport, a flight that may connect through a larger hub, and time away from work and family. If you can, bring a support person who can help with travel and later be part of the aftercare plan. Leave some buffer after treatment, too, because many people feel tired and tender in the days that follow.
Questions You May Still Be Asking
Does ibogaine get rid of fentanyl withdrawal symptoms?
For many people it reduces them, sometimes greatly, but response varies considerably, some people still experience lingering symptoms, and medical supervision is required throughout.
Is ibogaine legal in the United States?
No. Ibogaine is a Schedule I controlled substance in the United States and is not FDA-approved. All IWI ibogaine treatment happens at its medical clinic in Cozumel, Mexico.
What if I have been using fentanyl mixed with carfentanil or nitazenes?
An uncertain supply affects preparation and assessment, but it does not automatically rule you out. The Iboga Wellness Institute medical team evaluates your actual condition, history, test results, and medical findings rather than the label on what you were sold.
How long does ibogaine treatment take?
There is no fixed calendar. The length of your stay depends on your stability, your screening results, and how you respond, followed by structured integration once you are home.
Can I go back to Suboxone or methadone after ibogaine?
Yes. Medication for opioid use disorder remains an option if cravings return. Your discharge plan should name clinical options near you and when to reach out for help.
What happens if I return to use after ibogaine treatment?
It does not mean all is lost. Reach out early. The Iboga Wellness Institute integration team works with you to understand what happened and whether the plan needs to change. Because tolerance is lower, fast contact with medical care is especially important.
The First Step Is a Screening, Not a Promise
You have spent enough time on programs that sold certainty. What you need now is an honest medical answer about whether ibogaine is safe for your body, or your loved one’s, and realistic for your situation. You also need a plan that does not end when the flight lands back home.
Contact the IWI admissions team to schedule a confidential medical screening and learn whether ibogaine for fentanyl addiction is appropriate for your situation.
Before you call, write down four things: what has been used and for how long, any overdoses, every current medication, and every treatment already tried. That list gives the Iboga Wellness Institute medical team what it needs to judge real risk instead of guessing from the word “fentanyl.” It is also the first piece of work toward a life you no longer feel the need to escape from.
Important legal and safety information: Ibogaine is not approved by the FDA and is not available as a legal medical treatment in the United States. Iboga Wellness Institute provides ibogaine treatment exclusively at its licensed medical clinic in Cozumel, Mexico, under medical supervision. US locations handle admissions, screening, and aftercare coordination only.
Ready to explore whether ibogaine could be the turning point you’ve been searching for?
If fentanyl has resisted every other approach and you’re wondering whether this treatment might finally address the unique hold it has on your system, we understand that question. The Iboga Wellness Institute team can walk you through what ibogaine-assisted detoxification looks like at our licensed medical clinic in Cozumel, Mexico, answer your specific questions about safety and candidacy, and help you understand whether this path makes sense for your situation.
- Ibogaine is not approved by the FDA and is a Schedule I controlled substance in the United States.
- Iboga Wellness Institute provides ibogaine treatment only at its medical clinic in Cozumel, Mexico.
- This article is for education only and is not medical advice.
- Do not stop or change any prescribed medication without talking to your prescriber.
- Individual responses to treatment vary considerably, and outcomes described in this article reflect the experiences of some people but are not representative of all patients.


































